These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 17065642)
1. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. Stanley JR; Amagai M N Engl J Med; 2006 Oct; 355(17):1800-10. PubMed ID: 17065642 [No Abstract] [Full Text] [Related]
2. The molecular logic of pemphigus and impetigo: the desmoglein story. Amagai M Vet Dermatol; 2009 Oct; 20(5-6):308-12. PubMed ID: 20178466 [TBL] [Abstract][Full Text] [Related]
3. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome. Nagasaka T; Nishifuji K; Ota T; Whittock NV; Amagai M J Clin Invest; 2004 Nov; 114(10):1484-92. PubMed ID: 15545999 [TBL] [Abstract][Full Text] [Related]
4. [Loss of adhesive function of desmogleins in bullous diseases: pemphigus and impetigo]. Nishifuji K; Amagai M Tanpakushitsu Kakusan Koso; 2006 May; 51(6 Suppl):796-802. PubMed ID: 16719346 [No Abstract] [Full Text] [Related]
5. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Amagai M; Matsuyoshi N; Wang ZH; Andl C; Stanley JR Nat Med; 2000 Nov; 6(11):1275-7. PubMed ID: 11062541 [TBL] [Abstract][Full Text] [Related]
6. Differential pathomechanisms of epidermal necrolytic blistering diseases. Paquet P; Piérard GE Int J Mol Med; 2002 Dec; 10(6):695-9. PubMed ID: 12429994 [TBL] [Abstract][Full Text] [Related]
7. Desmoglein autoimmunity in the pathogenesis of pemphigus. Gniadecki R Autoimmunity; 2006 Nov; 39(7):541-7. PubMed ID: 17101497 [TBL] [Abstract][Full Text] [Related]
8. Desmosomes and disease: pemphigus and bullous impetigo. Payne AS; Hanakawa Y; Amagai M; Stanley JR Curr Opin Cell Biol; 2004 Oct; 16(5):536-43. PubMed ID: 15363804 [TBL] [Abstract][Full Text] [Related]
10. Desmoglein as a target in autoimmunity and infection. Amagai M J Am Acad Dermatol; 2003 Feb; 48(2):244-52. PubMed ID: 12582396 [TBL] [Abstract][Full Text] [Related]
12. Staphylococcal scalded skin syndrome. II. Serum level of anti exfoliatin and anti alpha-toxin in patients with staphylococcal scalded skin syndrome or bullous impetigo. Nishioka K; Nakano T; Hirao N; Teranishi H; Asada Y J Dermatol; 1977 Apr; 4(2):65-8. PubMed ID: 15461328 [TBL] [Abstract][Full Text] [Related]
13. Pemphigus: the promises of peptide immunotherapy. Di Bisceglie MB; Lucchese A; Crincoli V Immunopharmacol Immunotoxicol; 2009; 31(4):509-15. PubMed ID: 19874216 [TBL] [Abstract][Full Text] [Related]
14. Concurrence of bullous pemphigoid and herpetiform pemphigus with IgG antibodies to desmogleins 1/3 and desmocollins 1-3. Ohata C; Koga H; Teye K; Ishii N; Hamada T; Dainichi T; Furumura M; Sato M; Sueki H; Hashimoto T Br J Dermatol; 2013 Apr; 168(4):879-81. PubMed ID: 22924466 [No Abstract] [Full Text] [Related]
15. Treatment of bullous impetigo and the staphylococcal scalded skin syndrome in infants. Johnston GA Expert Rev Anti Infect Ther; 2004 Jun; 2(3):439-46. PubMed ID: 15482208 [TBL] [Abstract][Full Text] [Related]
16. [Desmoglein, the target molecule in autoimmunity and infection]. Amagai M Nihon Rinsho Meneki Gakkai Kaishi; 2006 Oct; 29(5):325-33. PubMed ID: 17075192 [TBL] [Abstract][Full Text] [Related]